Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Sarcoma, Ewing × Zoledronic Acid × Clear all

Phase

Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 24 Prostatic Neoplasms 12 Neoplasm Metastasis 11 Multiple Myeloma 8 Osteoporosis 7 Pain 6 Fractures, Bone 4 Neoplasms, Plasma Cell 3 Lung Neoplasms 3 Humoral Hypercalcemia Of Malignancy 3 Carcinoma, Non-Small-Cell Lung 3 Bone Neoplasms 3 Spinal Cord Compression 2 Neoplasms 2 Lymphoma 2 Hematologic Neoplasms 2 Bone Diseases, Metabolic 2 Triple Negative Breast Neoplasms 1 Treatment of Bone Metastases 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Sarcoma 1 Paraproteinemias 1 Osteosarcoma 1 Neoplastic Processes 1 Lymphoma, Non-Hodgkin 1 Imaging Examination Shows at Least One Site With Bone Metastases From Soild Tumors 1 Hematologic Diseases 1 Giant Cell Tumor of Bone 1 Disease Progression 1

Interventions

Vincristine 2 Ifosfamide 2 Etoposide 2 Doxorubicin 2 Cyclophosphamide 2 Busulfan 2 treosulfan 1 ganitumab 1 etoposide phosphate 1 Zoledronic Acid 1 Triptorelin Pamoate 1 Temozolomide 1 Radiosurgery 1 Radiation 1 Melphalan 1 Irinotecan 1 FANG vaccine 1 Diphosphonates 1 Dactinomycin 1 Cyproheptadine 1 Congresses as Topic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00987636 2019-10-22

EWING2008

University Hospital Muenster

Phase 3 Completed

Neoplasm Metastasis, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡